In 2001, Act 77 directed the Pennsylvania Department of Health to establish a health research program. Under this program research grants are awarded for clinical, health services, and biomedical research. Act 77 establishes two types of health research grants – formula (non-competitive) grants and non-formula (competitive grants). All entities receiving funds must follow certain reporting, monitoring and evaluation procedures.
The Pennsylvania Department of Health Institutional Review Board (IRB) works to make sure that human subjects are protected in research that involves the Department of Health.
PRAMS (Pregnancy Risk Assessment Monitoring System) is a joint research project between the Pennsylvania Department of Health and the Centers for Disease Control and Prevention (CDC). Its purpose is to find out why some babies are born healthy and others are not.
Administered by the Centers for Disease Control and Prevention since 1981, allows Pennsylvania the flexibility to determine key health problems in the state and devise outcome-oriented, population-based programs to address those problems.
Cancer Trial Access for Pennsylvania Patients
On October 24, 2018, Governor Wolf signed
Act 93 into law. The law mandates that a third-party nonprofit corporation or public charity that specializes in assisting cancer patients and increasing enrollment, retention and minority participation in cancer clinical trials register with a Department of Health-approved Pennsylvania college or university with a school of public health. In addition, third party entities shall update their registration annually (prior to July 1).
Drexel University has been designated by the Department of Health to manage the registration process of third-party entities per the requirements of Act 93. If you are a third-party reimbursement entity that is required to register under law, please click this link to begin the registration process: